BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10718366)

  • 1. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.
    Watanabe M; Chigusa M; Takahashi H; Nakamura J; Tanaka H; Ohno T
    In Vitro Cell Dev Biol Anim; 2000 Feb; 36(2):104-9. PubMed ID: 10718366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
    Tang X; Zhang J; Chen Y; Lan Z; Wang C
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and characterization of a human ureteral cancer cell line producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Tanaka S; Iwasaki H; Nishida T; Watanabe R; Jouzaki H; Kikuchi M
    Hum Cell; 1991 Mar; 4(1):44-50. PubMed ID: 1888704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue.
    Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR
    J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and characterization of human pancreatic adenocarcinoma cell line SOJ producing carcinoembryonic antigen and carbohydrate antigen 19-9].
    Fujii Y; Sekiguchi M; Shiroko Y; Shimizu H; Sugawara I; Hasumi K; Eriguchi M; Ikeuchi T; Uchida H
    Hum Cell; 1990 Mar; 3(1):31-6. PubMed ID: 2083222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers as a diagnostic key for hilar cholangiocarcinoma.
    Juntermanns B; Radunz S; Heuer M; Hertel S; Reis H; Neuhaus JP; Vernadakis S; Trarbach T; Paul A; Kaiser GM
    Eur J Med Res; 2010 Aug; 15(8):357-61. PubMed ID: 20947473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between CA19-9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT-2).
    Iwamura T; Taniguchi S; Kitamura N; Yamanari H; Kojima A; Hidaka K; Setoguchi T; Katsuki T
    J Gastroenterol Hepatol; 1992; 7(5):512-9. PubMed ID: 1391733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
    Minato H; Nakanuma Y; Terada T
    Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and characterization of a human colonic cancer cell line expressing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Atari E; Watanabe K; Yamashita K
    Hum Cell; 1992 Jun; 5(2):174-9. PubMed ID: 1390419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.
    Yano H; Iemura A; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M
    J Hepatol; 1996 Apr; 24(4):413-22. PubMed ID: 8738727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Sujino H; Nagamori S; Fujise K; Hasumura S; Homma S; Matsuura T; Shimizu K; Niiya M; Kameda H
    Hum Cell; 1988 Jun; 1(2):250-5. PubMed ID: 2979202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment and characterization of strain KE-24 derived from human colonic cancer].
    Yamashita K; Atari E; Watanabe K; Shinoda H; Yokozawa M
    Hum Cell; 1991 Jun; 4(2):145-9. PubMed ID: 1958633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2).
    Iwamura T; Katsuki T
    Gastroenterol Jpn; 1987 Oct; 22(5):640-6. PubMed ID: 2445616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and characterization of human colonic and gastric cancer cell lines].
    Ide K; Iwamura T; Katsuki T
    Hum Cell; 1988 Jun; 1(2):245-9. PubMed ID: 2979201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological study of the TK cholangiocarcinoma cell line with three-dimensional cell culture.
    Akiyoshi K; Kamada M; Akiyama N; Suzuki M; Watanabe M; Fujioka K; Ikeda K; Mizuno S; Manome Y
    Mol Med Rep; 2014 Apr; 9(4):1359-64. PubMed ID: 24535710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Tao LY; Cai L; He XD; Liu W; Qu Q
    Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a newly established cell line (JR-St) derived from human gastric signet ring cell cancer, producing tumor markers.
    Terano A; Nakada R; Mutoh H; Hiraishi H; Ota S; Shiina S; Shimada T; Itoh Y; Kimura K; Shiga J
    Gastroenterol Jpn; 1991 Feb; 26(1):7-13. PubMed ID: 1848829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of the human cholangiocarcinoma cell line HChol-Y1 in a serum-free, chemically defined medium.
    Yamaguchi N; Morioka H; Ohkura H; Hirohashi S; Kawai K
    J Natl Cancer Inst; 1985 Jul; 75(1):29-35. PubMed ID: 2989602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.